Kennedy Bio President Trent Hayes and Board of Advisor Eric Penney with PathogenDx weigh in on Elon Musk’s dual Coronavirus test results. Also hear updates on testing availability, new tests coming to market, Vaccine progress and distribution hurdles. www.kennedybio.com
Read MoreHere are the Top 5 questions that every corporate acquirer will ask when assessing an investment or acquisition opportunity.
Read MoreThe Bird story highlights of M&A.
Read MoreIndependent Sponsor model 101 - Mergers and acquisitions - Kennedy Capital
Read More